Item 5.07 Submission of Matters to a Vote of Security Holders.

On January 11, 2023, PepperLime Health Acquisition Corporation (the "Company") held an extraordinary general meeting of shareholders (the "Extraordinary General Meeting"). At the Extraordinary General Meeting, a total of 17,518,238 (82.4%) of the Company's issued and outstanding ordinary shares held of record at the close of business on November 30, 2022, the record date for the Extraordinary General Meeting, were present either in person or by proxy, which constituted a quorum for the transaction of business. A majority of at least two-thirds of the Company's shareholders as, being entitled to do so, voted (in person or by proxy) on the Extension Amendment Proposal at the Extraordinary General Meeting, which is described in more detail in the definitive proxy statement of the Company filed with the U.S. Securities and Exchange Commission (the "SEC") on December 19, 2022 (as supplemented from time to time, the "Definitive Proxy Statement").

The Extension Amendment Proposal - RESOLVED, as a special resolution, the extension of the date by which the Company must consummate an initial business combination from April 19, 2023, which is 18 months from the closing of our initial public offering, to October 19, 2023 by amending the Company's amended and restated memorandum and articles of association ("Articles"), in the form set forth in Annex A to the Definitive Proxy Statement, PROVIDED that this Extension Amendment Proposal shall not be approved or effective if: (1) as a consequence of redemptions of the Company's public shares submitted to the Company pursuant to Article 50.8 of the Articles in connection with the Extraordinary General Meeting held to approve this Extension Amendment Proposal the Company's net tangible assets would be less than US$5,000,001 following such redemptions; or (2) within two business days following the Extraordinary General Meeting to approve the Extension Amendment Proposal the board of directors of the Company resolves not to proceed with the Extension Amendment Proposal because submitted redemptions of the Company's Public Shares pursuant to Article 50.8 of the Articles in connection with the Extraordinary General Meeting held to approve this Extension Amendment Proposal would cause the Company's Trust Account to hold less than US$40,000,000.





   For       Against   Abstain   Broker Non-Votes
17,230,335   287,903      0            N/A

As there were sufficient votes to approve the Extension Amendment Proposal, the Adjournment Proposal described in the Definitive Proxy Statement was not presented to the Company's shareholders.




Item 8.01 Other Events.

In connection with the approval of the Extension Amendment Proposal at the Extraordinary General Meeting, holders of 15,753,079 of the Company's ordinary shares exercised their right to redeem those shares for cash at an approximate price of $10.25 per share, for an aggregate of approximately $161.51 million. Following the payment of the redemptions, the Trust Account will have a balance of approximately $12.78 million.

© Edgar Online, source Glimpses